289 related articles for article (PubMed ID: 21993424)
1. Blinding in randomized clinical trials: imposed impartiality.
Hróbjartsson A; Boutron I
Clin Pharmacol Ther; 2011 Nov; 90(5):732-6. PubMed ID: 21993424
[TBL] [Abstract][Full Text] [Related]
2. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.
Haahr MT; Hróbjartsson A
Clin Trials; 2006; 3(4):360-5. PubMed ID: 17060210
[TBL] [Abstract][Full Text] [Related]
3. An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods.
Devereaux PJ; Choi PT; El-Dika S; Bhandari M; Montori VM; Schünemann HJ; Garg AX; Busse JW; Heels-Ansdell D; Ghali WA; Manns BJ; Guyatt GH
J Clin Epidemiol; 2004 Dec; 57(12):1232-6. PubMed ID: 15617948
[TBL] [Abstract][Full Text] [Related]
4. The blind leading the blind: use and misuse of blinding in randomized controlled trials.
Miller LE; Stewart ME
Contemp Clin Trials; 2011 Mar; 32(2):240-3. PubMed ID: 21070890
[TBL] [Abstract][Full Text] [Related]
5. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding.
Hróbjartsson A; Forfang E; Haahr MT; Als-Nielsen B; Brorson S
Int J Epidemiol; 2007 Jun; 36(3):654-63. PubMed ID: 17440024
[TBL] [Abstract][Full Text] [Related]
6. Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials.
Boutron I; Tubach F; Giraudeau B; Ravaud P
J Clin Epidemiol; 2004 Jun; 57(6):543-50. PubMed ID: 15246122
[TBL] [Abstract][Full Text] [Related]
7. Blinding terminology used in reports of randomized controlled trials involving dogs and cats.
Giuffrida MA; Agnello KA; Brown DC
J Am Vet Med Assoc; 2012 Nov; 241(9):1221-6. PubMed ID: 23078571
[TBL] [Abstract][Full Text] [Related]
8. Changes in beliefs identify unblinding in randomized controlled trials: a method to meet CONSORT guidelines.
Rees JR; Wade TJ; Levy DA; Colford JM; Hilton JF
Contemp Clin Trials; 2005 Feb; 26(1):25-37. PubMed ID: 15837450
[TBL] [Abstract][Full Text] [Related]
9. Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid.
Akl EA; Sun X; Busse JW; Johnston BC; Briel M; Mulla S; You JJ; Bassler D; Lamontagne F; Vera C; Alshurafa M; Katsios CM; Heels-Ansdell D; Zhou Q; Mills E; Guyatt GH
J Clin Epidemiol; 2012 Mar; 65(3):262-7. PubMed ID: 22200346
[TBL] [Abstract][Full Text] [Related]
10. Blinding in randomised trials: hiding who got what.
Schulz KF; Grimes DA
Lancet; 2002 Feb; 359(9307):696-700. PubMed ID: 11879884
[TBL] [Abstract][Full Text] [Related]
11. A review of blinding in randomized controlled trials found results inconsistent and questionable.
Boutron I; Estellat C; Ravaud P
J Clin Epidemiol; 2005 Dec; 58(12):1220-6. PubMed ID: 16291465
[TBL] [Abstract][Full Text] [Related]
12. Influence of blinding on treatment effect size estimate in randomized controlled trials of oral health interventions.
Saltaji H; Armijo-Olivo S; Cummings GG; Amin M; da Costa BR; Flores-Mir C
BMC Med Res Methodol; 2018 May; 18(1):42. PubMed ID: 29776394
[TBL] [Abstract][Full Text] [Related]
13. Reporting of outcomes in orthopaedic randomized trials: does blinding of outcome assessors matter?
Poolman RW; Struijs PA; Krips R; Sierevelt IN; Marti RK; Farrokhyar F; Bhandari M
J Bone Joint Surg Am; 2007 Mar; 89(3):550-8. PubMed ID: 17332104
[TBL] [Abstract][Full Text] [Related]
14. The quality of reporting and outcome measures in randomized clinical trials related to upper-extremity disorders.
Gummesson C; Atroshi I; Ekdahl C
J Hand Surg Am; 2004 Jul; 29(4):727-34; discussion 735-7. PubMed ID: 15249101
[TBL] [Abstract][Full Text] [Related]
15. Assessment of blinding in clinical trials.
Bang H; Ni L; Davis CE
Control Clin Trials; 2004 Apr; 25(2):143-56. PubMed ID: 15020033
[TBL] [Abstract][Full Text] [Related]
16. Pre-trial evaluation of the potential for unblinding in drug trials: a prototype example.
Walter SD; Awasthi S; Jeyaseelan L
Contemp Clin Trials; 2005 Aug; 26(4):459-68. PubMed ID: 16054578
[TBL] [Abstract][Full Text] [Related]
17. Is it possible to blind a trial for community-acquired pneumonia?
Boucher HW
Clin Infect Dis; 2008 Dec; 47 Suppl 3():S210-5. PubMed ID: 18986292
[TBL] [Abstract][Full Text] [Related]
18. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.
Fergusson D; Glass KC; Waring D; Shapiro S
BMJ; 2004 Feb; 328(7437):432. PubMed ID: 14761905
[TBL] [Abstract][Full Text] [Related]
19. Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic review.
Boutron I; Estellat C; Guittet L; Dechartres A; Sackett DL; Hróbjartsson A; Ravaud P
PLoS Med; 2006 Oct; 3(10):e425. PubMed ID: 17076559
[TBL] [Abstract][Full Text] [Related]
20. Unreported formal assessment of unblinding occurred in 4 of 10 randomized clinical trials, unreported loss of blinding in 1 of 10 trials.
Bello S; Moustgaard H; Hróbjartsson A
J Clin Epidemiol; 2017 Jan; 81():42-50. PubMed ID: 27555081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
